{{Rsnum
|rsid=3867498
|Gene=SNRPN
|Chromosome=15
|position=24833640
|Orientation=plus
|GMAF=0.1056
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SNRPN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.3 | 28.3 | 4.4
| HCB | 97.8 | 2.2 | 0.0
| JPT | 89.4 | 10.6 | 0.0
| YRI | 88.4 | 11.6 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 77.2 | 20.8 | 2.0
| LWK | 88.2 | 10.9 | 0.9
| MEX | 86.2 | 13.8 | 0.0
| MKK | 85.9 | 13.5 | 0.6
| TSI | 70.6 | 23.5 | 5.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs3867498
|PubMedID=17903307
|Condition=Other pulmonary function traits
|Gene=SNRPN
|Risk Allele=
|pValue=1.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs3867498
|Name_s=
|Gene_s=SNRPN
|Feature=
|Evidence=PubMed ID:17903307; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study genome-wide association: results for pulmonary function measures (Initial Sample Size: 1,097-1,222 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with pulmonary function traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356435
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3867498
|overall_frequency_n=14
|overall_frequency_d=128
|overall_frequency=0.109375
|n_genomes=13
|n_genomes_annotated=0
|n_haplomes=14
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}